OBJECTIVE: A pilot study was conducted to determine the feasibility and potential efficacy of an interactive voice response (IVR) follow-up system for smokers recently hospitalized with coronary heart disease (CHD). METHODS:Ninety-nine smokers hospitalized with CHD completed a baseline questionnaire, were provided with bedside counseling, and offered nicotine replacement therapy. They were randomly assigned to a usual care (UC) or an IVR group. The IVR group received automated telephone follow-up calls 3, 14 and 30 days after discharge inquiring about their smoking status and confidence in remaining smoke-free. When deemed necessary, they were offered additional counseling. Smoking status was determined 52 weeks after hospital discharge. RESULTS: The 52-week point prevalence abstinence rate in the IVR group was 46.0% compared to 34.7% in the UC group (OR=1.60, 95% CI: 0.71-3.60; P=.25). After adjustment for education, age, reason for hospitalization, length of hospitalization, and quit attempts in the past year, the odds of quitting in the IVR group compared to the UC group were 2.34 (95% CI: 0.92-5.92; P=.07). CONCLUSIONS: IVR is a promising technology for following CHD patients attempting to quit smoking following discharge from hospital, however, a larger trial is required to confirm its efficacy. PRACTICE IMPLICATIONS: IVR may enhance the timely provision of follow-up counseling for smoking cessation in patients with CHD.
RCT Entities:
OBJECTIVE: A pilot study was conducted to determine the feasibility and potential efficacy of an interactive voice response (IVR) follow-up system for smokers recently hospitalized with coronary heart disease (CHD). METHODS: Ninety-nine smokers hospitalized with CHD completed a baseline questionnaire, were provided with bedside counseling, and offered nicotine replacement therapy. They were randomly assigned to a usual care (UC) or an IVR group. The IVR group received automated telephone follow-up calls 3, 14 and 30 days after discharge inquiring about their smoking status and confidence in remaining smoke-free. When deemed necessary, they were offered additional counseling. Smoking status was determined 52 weeks after hospital discharge. RESULTS: The 52-week point prevalence abstinence rate in the IVR group was 46.0% compared to 34.7% in the UC group (OR=1.60, 95% CI: 0.71-3.60; P=.25). After adjustment for education, age, reason for hospitalization, length of hospitalization, and quit attempts in the past year, the odds of quitting in the IVR group compared to the UC group were 2.34 (95% CI: 0.92-5.92; P=.07). CONCLUSIONS: IVR is a promising technology for following CHD patients attempting to quit smoking following discharge from hospital, however, a larger trial is required to confirm its efficacy. PRACTICE IMPLICATIONS: IVR may enhance the timely provision of follow-up counseling for smoking cessation in patients with CHD.
Authors: Nancy A Rigotti; Yuchiao Chang; Lisa C Rosenfeld; Sandra J Japuntich; Elyse R Park; Hilary A Tindle; Douglas E Levy; Zachary Z Reid; Joanna Streck; Timothy Gomperts; Jennifer H K Kelley; Daniel E Singer Journal: J Gen Intern Med Date: 2017-06-14 Impact factor: 5.128
Authors: Benjamin A Toll; Steve Martino; Amy Latimer; Peter Salovey; Stephanie O'Malley; Shannon Carlin-Menter; Jessica Hopkins; Ran Wu; Paula Celestino; K Michael Cummings Journal: J Natl Cancer Inst Date: 2010-01-07 Impact factor: 13.506
Authors: Fabio A Almeida; Kimberlee A Pardo; Richard W Seidel; Brenda M Davy; Wen You; Sarah S Wall; Erin Smith; Mark H Greenawald; Paul A Estabrooks Journal: Contemp Clin Trials Date: 2014-06-21 Impact factor: 2.226
Authors: John D Piette; Milton O Mendoza-Avelares; Martha Ganser; Muhima Mohamed; Nicolle Marinec; Sheila Krishnan Journal: Am J Prev Med Date: 2011-06 Impact factor: 5.043
Authors: Martin C Mahoney; Deborah O Erwin; Christy Widman; Annamaria Masucci Twarozek; Frances G Saad-Harfouche; Willie Underwood; Chester H Fox Journal: Health Educ Behav Date: 2013-11-26
Authors: John D Piette; Ann-Marie Rosland; Nicolle S Marinec; Dana Striplin; Steven J Bernstein; Maria J Silveira Journal: Med Care Date: 2013-03 Impact factor: 2.983
Authors: John D Piette; Hema Datwani; Sofia Gaudioso; Stephanie M Foster; Joslyn Westphal; William Perry; Joel Rodríguez-Saldaña; Milton O Mendoza-Avelares; Nicolle Marinec Journal: Telemed J E Health Date: 2012-10 Impact factor: 3.536